PDF(Pubmed)
Abstract：
The indications for cochlear implantation have expanded over time due to evidence demonstrating identification and implantation of appropriate cochlear implant (CI) candidates lead to significant improvements in speech recognition and quality of life (QoL). However, clinical practice is variable, with some providers using outdated criteria and others exceeding current labeled indications. As a results, only a fraction of those persons who could benefit from CI technology receive it. This document summarizes the current evidence for determining appropriate referrals for adults with bilateral hearing loss into CI centers for formal evaluation by stressing the importance of treating each ear individually and a \"revised 60/60 rule\". By mirroring contemporary clinical practice and available evidence, these recommendations will also provide a standardized testing protocol for CI candidates using a team-based approach that prioritizes individualized patient care. This manuscript was developed by the Adult Cochlear Implantation Candidacy Task Force of the American Cochlear Implant Alliance using review of the existing literature and clinical consensus. LEVEL OF EVIDENCE: N/A Laryngoscope, 134:S1-S14, 2024.
摘要：
随着时间的推移，耳蜗植入的适应症已经扩大，因为有证据表明识别和植入适当的耳蜗植入物（CI）可以显着改善语音识别和生活质量（QoL）。然而,临床实践是可变的，一些提供商使用过时的标准，另一些提供商使用超过当前标记的适应症。作为一个结果,只有一小部分人可以从CI技术中受益。本文件通过强调单独治疗每只耳朵的重要性和“修订后的60/60规则”，总结了确定双侧听力损失成人适当转诊到CI中心进行正式评估的当前证据。通过反映当代临床实践和现有证据，这些建议还将为CI候选人提供标准化的检测方案,采用以团队为基础的方法,优先考虑个性化患者护理.该手稿是由美国人工耳蜗植入联盟的成人人工耳蜗植入候选人工作组在回顾现有文献和临床共识的基础上开发的。证据水平：不适用喉镜，2023年。
